<?xml version="1.0" encoding="UTF-8"?>
<p>Respiratory infection is one of the main routes by which patients acquire Ads. To test whether prophylactic administration of VGCV can affect the outcome of respiratory Ad6 infection, we tested the efficacy of VGCV against i.n. challenge with the virus. We pipetted the virus dose into the nostrils of anesthetized hamsters, which inhaled the liquid, thus delivering the virus to the lower airways [
 <xref rid="B29-viruses-09-00147" ref-type="bibr">29</xref>]. For the VGCV-treated animals, we used the same drug dose and dosing schedule as for the i.v. experiment. 
</p>
